Maternal morbidity and mortality in cases of placenta accreta: a management protocol analysis Hospital de san José, Bogotá DC.
Morbimortalidad de gestantes con acretismo placentario análisis del protocolo de manejo del Hospital de San José, Bogotá DC.
Main Article Content
Abstract
Objective: to describe maternal morbidity and mortality in cases of placenta accreta using Hospital de San José, Bogotá DC management protocol. Materials and Methods: a descriptive retrospective observational study of ali cases of placenta accreta covered by the protocol used at HSJ to manage placent accreta. There were no exclusion criteria. Excel 2007 was used to create a database and STATA 10 for data analysis. Results: Twenty-nine patients with mean age 34 years (SD 3.6) were included. An antecedent history of surgical procedure was present in 96.5 % . Average hospital stay was five days (SD 1.6). Fifty-two percent (52%) required blood producís transfusion and 10.3% underwent a massive transfusion. Surgery - related complications occurred in 17.2%. Infection and disseminated intravascular coagulation were the most common postoperative complications (4.1 % and 8.3% ). Admission into the ICU was required in 24.1 % with a maximum stay of 3 days. Inotropic support and mechanical ventilation (20.7% and 20.7%) were the most common forms of ICU support. There were no maternal deaths. Conclusions: the use of Hospital de San José placenta accreta management protocol resulted in short hospital stay and few complications and need of admission to the ICU compared to that reported in literature.
Downloads
Article Details
References
2. Lewis G. Beyond the numbers: reviewing maternal deatbs and complications to make pregnancy safer. Br Med Bull. 2003;67:27-37.
3. Vélez AGea. Guía para el manejo de la hemorragia obstétrica. Rev. colomb. obs te!. ginecol. 2009;60(1):34-48.
4. Dane.gov.co[página en Internet]. Bogotá: DANE; 2012. [actualizado 30 Ene. 2012; citado 31 Ene 2012]. Disponible en: http://www.dane.gov.co
5. Anderson JM, Etches D. Prevention and management of postpartum hemorrhage. Am Fam Physician. 2007;75(6):875-82.
6. Devine PC. Obstetric hemorrhage. Semin Perinatol. 2009; 33(2):76-81.
7. Zamora P, García Oms J, Royo S, Sánchez M, et al. Tratamiento médico y qui rúrgico de las hemorragias postparto y del alumbramiento. Ginecol. obstet. clín. 2003;4(2):70-79.
8. Fawcus S. Tratamientos para la hemorragia postparto primaria: Comentario de la BSR [monografía en Internet]. Ginebra: OMS; 2012 [actualizado 8 Mayo 2007; citado 31 Ene 2012]. Disponible en: http://apps.who.int/rhl/pregnancy childbir tb/cbildbirtb/postpartum_haemorrhage/sfcom/es/index.html
9. Dueñas O, Rico H, Rodríguez M. Actualidad en el diagnóstico y manejo del acretismo placentario. Rev Chil Obstet Gineco. 2007; 4(72): 266-71.
10. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa placenta accreta. Am J Obstet Gynecol. 1997;177(1): 210-14.
11. Woollard LA. Postpartum haemorrhage occurrence and recurrence: a population based study. Med J Aust. 2008;188 (12):731.
12. Chou MM, Ho ES, Lee YH. Prenatal diagnosis of placenta previa acere ta by transabdominal color Doppler ultrasound. lTTtrasound Obstet Gynecol. 2000;15(1):28-35.
13. Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound Obstet Gynecol. 2005; 26(1):89-96.
14. Clark SL. Placenta previa and abruptio placentae. In: Maternal-fetal medicine: principies and practice. 5th ed. Philadelphia: Saunders; 2004: 707-22.
15. Warshak CR, Eskander R, Hui! AD et al. Accuracy of ultrasonography and mag netic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol. 2006;108 (3 PI 1): 573-8l.
16. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 2006;107(4): 927-41.
17. Gielchinsky Y, Mankuta D, Rojansky N, Laufer N, Gielchinsky I, Ezra Y. Peri natal outcome of pregnancies complicated by placenta accreta. Obste! Gynecol. 2004;104(3): 527-30.
18. Chestnut OH, Dewan DM, Redick LF, Catan D, Spielman FJ. Anestbetic mana gement for obstetric hysterectomy: a multi-institutional study. Anestbesiology. 1989; 70(4): 607-10.
19. Chou MM, Tseng JJ, Ho ES, Hwang JI. Three-dimensional color power Doppler imaging in the assessment of uteroplacental neovascularization in placenta previa increta/percreta. Am J Obste! Gynecol. 2001; 185(5): 1257-60.
20. Bernischke KP. Placenta! sbape aberrations. In: Patbology of tbe human placenta. 4tb ed. New York: Springer; 2000. p. 399-418.
21. Hudon L, Belfort MA, Broome DR. Diagnosis and management of placenta percreta: a review. Obstet Gynecol Surv. 1998; 53(8):509-17.
22. Angstmann T, Gard G, Harrington T, Ward E, Thomson A, Giles W. Surgical management of placenta accreta: a cohort series and suggested approach. Am J Obstet Gynecol. 2010; 202(1):38-9